Abbott Laboratories (ABT) | Stock Overview & Key Data
Abbott Laboratories Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: $142.60 on December 27, 2021
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Dividend Information
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 160.70B Large-cap | -2.02% | 4.97% | -19.35% | -30.98% | -28.60% | -34.98% | -16.97% | -20.08% | 135.84% | 255.56% | 329.52% | |
|
Stryker
SYK
|
126.25B Large-cap | 2.13% | 0.38% | -11.91% | -13.33% | -11.56% | -17.25% | 6.06% | 22.47% | 172.95% | 440.98% | 592.85% |
|
Medtronic plc
MDT
|
107.58B Large-cap | -0.38% | 5.55% | -8.91% | -18.45% | -16.31% | -8.10% | -10.04% | -34.92% | -4.68% | 110.00% | 59.60% |
| 97.63B Large-cap | -3.98% | -11.24% | -33.00% | -49.28% | -50.63% | -52.97% | -13.64% | 9.04% | 108.58% | 590.87% | 133.50% | |
| 48.52B Large-cap | 0.50% | 6.02% | 3.26% | 3.48% | 1.11% | 13.25% | -7.43% | -15.49% | 159.09% | 507.93% | 2,151.59% | |
|
Dexcom
DXCM
|
23.76B Large-cap | -3.13% | 20.43% | 11.88% | 12.92% | 11.54% | -8.07% | -42.07% | -27.92% | 315.26% | 2,149.85% | 2,129.88% |
Ownership & Short Interest
Calculate Your Abbott Laboratories Investment Returns
Long-Term Investment Performance Analysis
Abbott Laboratories stock price in Jul 2016 was $43.17, A $1,000.00 lump sum investment in Abbott Laboratories made 9 years ago would be worth approximately $2,053.97 today, representing a strong return of 105.40%. This translates to an annualized return (CAGR) of 7.53%.
9 Years 10 Months Investment Scenario (Jul 2016 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is ABT's 52-week high and low?
- In the last 52 weeks, Abbott Laboratories reached a high of $139.06 (on June 24, 2025) and a low of $81.97 (on May 11, 2026).
- What is the market cap and P/E ratio for ABT?
- Curious about Abbott Laboratories's size and valuation? Its market capitalization stands at 160.70B. When it comes to valuation, the P/E ratio (trailing twelve months) is 25.97, and the forward P/E (looking ahead) is 15.29.
- Does ABT pay dividends? If so, what's the yield?
- Yes, Abbott Laboratories is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 1.97%, and the company has paid an average of $2.24 per share annually over the past 3 years.
- Who are Abbott Laboratories's main competitors or similar companies to consider before investing?
When looking at Abbott Laboratories, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Stryker
SYK126.25B Healthcare Medical Devices -17.25% 6.06% Medtronic plc
MDT107.58B Healthcare Medical Devices -8.10% -10.04% Boston Scientific
BSX97.63B Healthcare Medical Devices -52.97% -13.64% Edwards Lifesciences
EW48.52B Healthcare Medical Devices 13.25% -7.43% Dexcom
DXCM23.76B Healthcare Medical Devices -8.07% -42.07% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Abbott Laboratories? (e.g., ROE, Debt/Equity)
- To get a sense of Abbott Laboratories's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 12.36%, the Debt to Equity ratio from the most recent quarter is 26.79, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for ABT?
- Looking at Abbott Laboratories's growth, its revenue over the trailing twelve months (TTM) was $45B. Compared to the same quarter last year (YoY), quarterly revenue grew by 7.80%, and quarterly earnings saw a YoY growth of -18.70%.
- How much of ABT stock is held by insiders and institutions?
- Wondering who owns Abbott Laboratories stock? Company insiders (like executives and directors) hold about 0.54% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 82.23%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.